Abolis Biotechnologies, a pioneering French startup specializing in microbial solutions for industrial applications, has successfully raised €35 million in a new funding round. This investment is led by a consortium of prominent international investors, including BOLD, L’Oréal’s venture capital fund, Evonik Venture Capital, and several impact-focused funds such as DeepTech & Climate Fonds…
